Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jemima Albayda

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Neurology|January 23, 2023
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body MyositisElizabeth Harlan Michelle, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
The phenotype of myositis patients with anti-Ku autoantibodiesMaria Casal-Dominguez, Iago Pinal-Fernandez, Assia Derfoul, et al.
Annals of the Rheumatic Diseases|September 22, 2016
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severityIago Pinal-Fernandez, Maria Casal-Dominguez, John A Carrino, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathyEleni Tiniakou, Alex Girgis, Tiara Siafei, et al.
Annals of the Rheumatic Diseases|October 11, 2024
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathyEleni Tiniakou, Alex Girgis, Tiara Siafei, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 1, 2020
Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten PatientsJulie J Paik, Livia Casciola-Rosen, Joseph Yusup Shin, et al.
Neurology|May 6, 2018
Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodiesRebecca De Lorenzo, Iago Pinal-Fernandez, Wilson Huang, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumabLaura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
Arthritis Care & Research|March 13, 2023
Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis PatientsChristopher A Mecoli, Brant Chee, Mengkun Chen, et al.
Neurology|October 10, 2019
More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodiesIago Pinal-Fernandez, Christopher A Mecoli, Maria Casal-Dominguez, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Neurology|January 23, 2023
Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body MyositisElizabeth Harlan Michelle, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
The phenotype of myositis patients with anti-Ku autoantibodiesMaria Casal-Dominguez, Iago Pinal-Fernandez, Assia Derfoul, et al.
Annals of the Rheumatic Diseases|September 22, 2016
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severityIago Pinal-Fernandez, Maria Casal-Dominguez, John A Carrino, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathyEleni Tiniakou, Alex Girgis, Tiara Siafei, et al.
Annals of the Rheumatic Diseases|October 11, 2024
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathyEleni Tiniakou, Alex Girgis, Tiara Siafei, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 1, 2020
Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten PatientsJulie J Paik, Livia Casciola-Rosen, Joseph Yusup Shin, et al.
Neurology|May 6, 2018
Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodiesRebecca De Lorenzo, Iago Pinal-Fernandez, Wilson Huang, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumabLaura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
Arthritis Care & Research|March 13, 2023
Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis PatientsChristopher A Mecoli, Brant Chee, Mengkun Chen, et al.
Neurology|October 10, 2019
More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodiesIago Pinal-Fernandez, Christopher A Mecoli, Maria Casal-Dominguez, et al.
Pageof 8